An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to

  • Slides: 5
Download presentation
An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatinresistant Bladder Cancer Roland Seiler, Htoo

An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatinresistant Bladder Cancer Roland Seiler, Htoo Zarni Oo, Davide Tortora, Thomas M. Clausen, Chris K. Wang, Gunjan Kumar, Marina Ayres Pereira, Maj S. Ørum. Madsen, Mette Ø. Agerbæk, Tobias Gustavsson, Mie A. Nordmaj, Jamie R. Rich, Nada Lallous, Ladan Fazli, Sherry S. Lee, James Douglas, Tilman Todenhöfer, Shaghayegh Esfandnia, Dulguun Battsogt, John S. Babcook, Nader Al-Nakouzi, Simon J. Crabb, Igor Moskalev, Bernhard Kiss, Elai Davicioni, George N. Thalmann, Paul S. Rennie, Peter C. Black, Ali Salanti, Mads Daugaard European Urology Volume 72 Issue 1 Pages 142 -150 (July 2017) DOI: 10. 1016/j. eururo. 2017. 03. 021 Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 1 European Urology 2017 72142 -150 DOI: (10. 1016/j. eururo. 2017. 03. 021)

Fig. 1 European Urology 2017 72142 -150 DOI: (10. 1016/j. eururo. 2017. 03. 021) Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 2 European Urology 2017 72142 -150 DOI: (10. 1016/j. eururo. 2017. 03. 021)

Fig. 2 European Urology 2017 72142 -150 DOI: (10. 1016/j. eururo. 2017. 03. 021) Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 3 European Urology 2017 72142 -150 DOI: (10. 1016/j. eururo. 2017. 03. 021)

Fig. 3 European Urology 2017 72142 -150 DOI: (10. 1016/j. eururo. 2017. 03. 021) Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 4 European Urology 2017 72142 -150 DOI: (10. 1016/j. eururo. 2017. 03. 021)

Fig. 4 European Urology 2017 72142 -150 DOI: (10. 1016/j. eururo. 2017. 03. 021) Copyright © 2017 European Association of Urology Terms and Conditions

Targeting the 5 T 4 oncofetal glycoprotein withTargeting the 5 T 4 oncofetal glycoprotein with
Genistein Enhances or Reduces Glycosaminoglycan Quantity in aGenistein Enhances or Reduces Glycosaminoglycan Quantity in a
Glycosaminoglycan Modulates Growth Factor Signaling Heparan Sulfate andGlycosaminoglycan Modulates Growth Factor Signaling Heparan Sulfate and
Dermatan Sulfate Proteoglycan and Glycosaminoglycan Synthesis Is InducedDermatan Sulfate Proteoglycan and Glycosaminoglycan Synthesis Is Induced